Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- bs-1459R - Provider product page
- Provider
- Bioss
- Proper citation
- Bioss Cat#bs-1459R, RRID:AB_10855104
- Product name
- IL-6R Beta/CD130/gp130 Antibody
- Antibody type
- Polyclonal
- Description
- KLH conjugated synthetic peptide derived from mouse IL6R beta
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100ul
- Concentration
- 1ug/ul
- Storage
- Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for 12 months.
Submitted references TMEM100 mediates inflammatory cytokines secretion in hepatic stellate cells and its mechanism research.
Overexpression and correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular carcinoma following high-intensity focused ultrasound treatment: Implications for tumor recurrence and progression.
MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line.
Pan LX, Li LY, Zhou H, Cheng SQ, Liu YM, Lian PP, Li L, Wang LL, Rong SJ, Shen CP, Li J, Xu T
Toxicology letters 2019 Dec 15;317:82-91
Toxicology letters 2019 Dec 15;317:82-91
Overexpression and correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular carcinoma following high-intensity focused ultrasound treatment: Implications for tumor recurrence and progression.
Wu L, Zhang YS, Ye ML, Shen F, Liu W, Hu HS, Li SW, Wu HW, Chen QH, Zhou WB
Experimental and therapeutic medicine 2017 Jun;13(6):3529-3534
Experimental and therapeutic medicine 2017 Jun;13(6):3529-3534
MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line.
Liu Y, Han S, Li Y, Liu Y, Zhang D, Li Y, Zhang J
Oncology letters 2017 Aug;14(2):1780-1786
Oncology letters 2017 Aug;14(2):1780-1786
No comments: Submit comment
Supportive validation
- Submitted by
- Bioss (provider)
- Main image
- Experimental details
- Formalin-fixed and paraffin embedded human endometrial cancer labeled with Anti-IL-6R Beta/CD130/gp130 Polyclonal Antibody, Unconjugated (bs-1459R) followed by conjugation to the secondary antibody and DAB staining
- Sample type
- Human
- Other comments
- Uterus
- Submitted by
- Bioss (provider)
- Main image
- Experimental details
- Formalin-fixed and paraffin embedded human endometrial cancer labeled with Anti-IL-6R Beta/CD130/gp130 Polyclonal Antibody, Unconjugated (bs-1459R) followed by conjugation to the secondary antibody and DAB staining
- Sample type
- Human
- Other comments
- Uterus
